- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
CI
Even After Earnings Beat, Cigna Corporation Stock Still Looks Stuck
Cigna Corporation stock has had an ugly 2018 so far. And given the wait ahead of its Express Scripts acquisition, the Q1 earnings beat is unlikely to change the trend for CI stock.
The 7 Most Undervalued Stocks In Larry Robbins’ Portfolio
Larry Robbins is a well-known GARP investor. Here are some of his hedge fund's -- Glenview Capital Management -- most undervalued stocks.
The Reviews for the Cigna Corporation-ExpressScripts Deal Are In…And Bad
Analysts are skeptical that buying the largest Pharmacy Benefit Manager will help make Cigna -- one of the smaller health insurers -- more profitable.
Cigna Corporation Is Too Late to the Party
Cigna is paying more than its own market cap for ExpressScripts, the largest Pharmacy Benefit Manager.
Stocks Continue to Waver as Trump Unveils Tariffs
Stocks finished mixed on Thursday as President Trump finally unveiled the steel and aluminum tariffs that were hinted at last week.
Express Scripts Holding Co Stock Soars on Cigna Corporation Deal
Express Scripts (ESRX) stock was on the rise Thursday following news of a deal with Cigna (CI) that will have the two companies merging together.
What Remains For Rite Aid Corporation? The Risks of Going It Alone
Rite Aid bulls hope it finds a buyer, while bears see it circling the drain. RAD stock might be fun to trade right now, but watch it closely.
Exceptional Quant Score Keeps Cigna (CI) a Strong Buy
The current recommendation of Strong Buy for Cigna Corporation (NYSE:CI) is computed using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology. CI has maintained this ranking for 4 months.
Cigna (CI) a Strong Buy on Exceptional Earnings Momentum
Cigna Corporation (NYSE:CI) is one of the 782 companies in the GICS Health Care sector, and a member of the 82 company Health Care Providers & Services GICS industry group within this sector. The market value of CI is $51.6 billion which places it in the top decile in its industry group. The stock's current Portfolio Grader score places it 3 among the 82 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 15 among the 782 companies in the sector, and number 98 in the nearly 5,000 company Portfolio Grader universe.
Stellar Measures for Earnings Growth Make Cigna (CI) a Strong Buy
Cigna Corporation (NYSE:CI) is a member of the 82 company Health Care Providers & Services GICS industry group, which is a segment of the 781 company GICS Health Care sector. The market value of CI is $49.6 billion which places it in the top 10% of its industry group. The stock's current Portfolio Grader score places it 3 among the 82 companies in this industry group, putting it in the top decile; among the sector leaders with a ranking of 16 among the 781 companies in the sector, and number 97 in the nearly 5,000 company Portfolio Grader universe.
High-Level Measures for Earnings Momentum Make Cigna (CI) a Strong Buy
Currently, Cigna Corporation (NYSE:CI) has a Strong Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. CI has maintained this ranking for 3 months.
Top-End Earnings Momentum Makes Cigna (CI) a Strong Buy
Cigna Corporation (NYSE:CI) is a member of the 82 company Health Care Providers & Services GICS industry group, which is a segment of the 782 company GICS Health Care sector. CI has a market value of $49.0 billion which is in the top decile in its industry group. The stock's current Portfolio Grader score places it 4 among the 82 companies in this industry group, putting it in the top decile; among the sector leaders with a ranking of 13 among the 782 companies in the sector, and number 95 in the nearly 5,000 company Portfolio Grader universe.
Outstanding Earnings Visibility Keeps Cigna (CI) a Strong Buy
Portfolio Grader currently ranks Cigna Corporation (NYSE:CI) a Strong Buy. The methodology for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. CI has maintained this ranking for 3 months.
Cigna (CI) a Strong Buy on Superb Earnings Momentum
Cigna Corporation (NYSE:CI) is a $51.0 billion in market value member of the Health Care Providers & Services GICS industry group where the stock's current Portfolio Grader score places it 2 among the 82 companies in this industry group, positioning it among the leaders. CI is ranked among the sector leaders with a ranking of 11 among the 783 companies in the sector and number 57 in the 5000 company Portfolio Grader company universe.
Outstanding Quant Score Keeps Cigna (CI) a Strong Buy
The current recommendation of Strong Buy for Cigna Corporation (NYSE:CI) has been derived by using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 2 months.
Outstanding Quant Score Makes Cigna (CI) a Strong Buy
Portfolio Grader currently ranks Cigna Corporation (NYSE:CI) a Strong Buy. The methods for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking CI has had from Portfolio Grader for 2 months.
Strong Buy Ranking for Cigna (CI) Kept
Cigna Corporation (NYSE:CI) is ranked as a Strong Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. CI has maintained this ranking for the last month.
Strong Buy Ranking for Cigna (CI) Kept
Cigna Corporation (NYSE:CI) is ranked as a Strong Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. CI has maintained this ranking for the last month.
